Boston CAR-TCR Summit Raises $6k for Emily Whitehead Foundation
On September 6-7, we had the pleasure of attending the 3rd Annual CAR-TCR Summit in Boston. In partnership with the CAR-TCR Summit, the Emily Whitehead Foundation hosted a silent auction for the conference attendees and raised a total $6,000!
FDA Approves CAR-T Cell Treatment for Pediatric Patients with Acute Lymphoblastic Leukemia
This week marks a huge milestone for pediatric cancer research. The U.S. Food and Drug Administration (FDA) announced Wednesday that is has approved Novartis CAR-T cell therapy CTL019—now Kymriah—for pediatric patients with acute lymphoblastic leukemia (ALL)!
UMI Performance Cruise In & Autocross Event Raises $2500 for Emily Whitehead Foundation
On August 11-12 UMI Performance, Inc. hosted their UMI Performance Cruise In & Autocross. Proceeds from the event's bake sale and t-shirt sale benefitted EWF, which Minnesota-based Viking Performance, Inc. then generously matched to bring the total raised to $2500!
FDA Advisory Committee Unanimously Votes ‘YES’ to Pending Approval of CAR-T Cell Therapy CTL019
On Wednesday, July 12 the FDA's Oncologic Drugs Advisory Committee convened at a meeting to discuss the pending approval of CAR-T cell therapy CTL019. Our co-founders were present at the meeting, and Tom Whitehead spoke.
3rd Annual “Tee Off for T-Cells” Golf Tournament Raises Over $58,000
On Friday, July 14 we held our third annual "Tee Off for T-Cells" charity golf tournament at Philipsburg Elks Lodge & Country Club in Philipsburg, Pa. In the last three years, "Tee Off for T-Cells" has now raised more than $150,000 for pediatric cancer research.
Emily Whitehead Foundation and Jon Condo to Host 3rd Annual “Tee Off for T-Cells” Charity Golf Tournament
PRESS RELEASE - The Emily Whitehead Foundation will hold its third annual "Tee Off for T-Cells" charity golf tournament on Friday, July 14, 2017 at Philipsburg Elks Lodge & Country Club.
Tom Whitehead to Speak at FDA Approval Hearing for CAR-T Cell Therapy CTL019
Emily Whitehead Foundation co-founder Tom Whitehead has been accepted as a speaker for the Oncologic Drugs Advisory Committee (ODAC) meeting on July 12, 2017. At this hearing, the U.S. Food & Drug Association (FDA) will discuss the pending approval of CAR-T cell therapy CTL019.
Celebrating 5 Years Cancer Free!
We celebrated an incredible milestone this month — on May 10, 2017 Emily reached five years cancer free!
Our Co-Founder Nominated for Modern Hero
To many, Emily is a hero. Today, as she celebrates 5 years cancer free after T-cell therapy, Emily shares who her hero is—her mom and Emily Whitehead Foundation co-founder Kari Whitehead. Watch Kari's Modern Hero story!
Centre Gives 2017: Help Activate the Cure in Our Community
On May 9-10, 2017, the Emily Whitehead Foundation will participate in Centre Gives, a 36-hour online annual giving event sponsored by the Centre Foundation.
Kari Whitehead to Present at 2017 AACR Annual Meeting
Emily Whitehead Foundation co-founder Kari Whitehead will be attending the 2017 American Association for Cancer Research (AACR) Annual Meeting, held April 1 through April 5 at the Walter E. Washington Convention Center in Washington, D.C.
Pi Day 5k Benefitting Emily Whitehead Foundation
On Saturday, March 18 we teamed up with Left Right Repeat to hold the PI Day 5K Benefiting Emily Whitehead Foundation at Circleville Park in State College, Pa. Despite postponement due to inclement weather, the rescheduled Pi Day event was a success.